Results 111 to 120 of about 1,216 (154)

Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti–CD44-Based NIR-PIT

open access: yes, 2017
Oral cavity squamous cell carcinoma (OSCC) is considered one of the most aggressive subtypes of cancer. Anti-CD44 monoclonal antibodies (mAb) are a potential therapy against CD44 expressing OSCC; however, to date the therapeutic effects have been ...
Tadanobu Nagaya   +7 more
core   +1 more source

Supplementary Figures S1-S8 from Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen

open access: yes, 2016
Figure S1: Related PSMA ligands Figure S2: Schematic illustration for the synthesis of PSMA-1-SMCC and characterization of PSMA-1-SMCC Figure S3: Schematic illustration for the synthesis of PSMA-1-Pc413 and characterization of PSMA-1-Pc413 Figure S4 ...
James P. Basilion (94283)   +8 more
core   +1 more source

Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin–Antibody Conjugate

open access: yes, 2018
Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective tumor treatment that uses an antibody–photoabsorber conjugate (APC). However, the effect of NIR-PIT can be enhanced when combined with other therapies.
Tadanobu Nagaya   +8 more
core   +1 more source

Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy

open access: yes, 2018
Photochemical reactions can dramatically alter physical characteristics of reacted molecules. In this study, we demonstrate that near-infrared (NIR) light induces an axial ligand-releasing reaction, which dramatically alters hydrophilicity of a silicon ...
Shuhei Okuyama (3955442)   +14 more
core   +1 more source

Near-infrared photoimmunotherapy using antiGD2 antibody for neuroblastoma and osteosarcoma

open access: yesEJC Paediatric Oncology
Introduction: Near-infrared photoimmunotherapy (NIR-PIT) is a novel cancer therapy that specifically targets cancer cells. In NIR-PIT, antibody-photo-absorber-conjugates (APCs), specific for cancer antigens, target cancer cells.
Jimei Zhao   +7 more
doaj   +1 more source

Supplementary Figure S3: The characteristics of SKOV-3/Luc cells from Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer

open access: yes, 2016
The characteristics of SKOV-3/Luc cells. The human ovarian cancer cell line SKOV-3/Luc is known to be HER2-positive. A, Western blot analysis showed the expression of wt-HER2 protein (185 kDa) in SKOV-3/Luc cells, the same as in N87 cells.
Michihiro Ishida (15069690)   +9 more
core   +1 more source

Internalization-Dependent EGFR-Targeted Photoactivation by Cetuximab-I21 Conjugates. [PDF]

open access: yesJ Immunother
Shang W   +6 more
europepmc   +1 more source

Mirabody–IR700: A novel EGFR-targeting platform for photoimmunotherapy

open access: yesBiomedicine & Pharmacotherapy
Citra R.A.P. Palangka   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy